Background: Flow-mediated dilatation (FMD) of the brachial artery is commonly measured as a surrogate marker of endothelial function. Its measurement is, however, technically demanding and reports regarding its reproducibility have not always been favourable. Aim: Two Type I diabetes and control group comparator studies were conducted to assess the reproducibility of FMD and to analyse blood flow data normally discarded during FMD measurement. Design: The studies were sequential and differed only with regard to operator and ultrasound machine. Seventy-two subjects with diabetes and 71 controls were studied in total. Methods: Subjects had FMD measured conventionally. Blood velocity waveforms were averaged over 10 pulses post forearm ischaemia and their
Introduction
Cost-effective prescribing for the prevention of cardiovascular disease is dependent on an accurate means of calculating risk for an individual, and multiple tools are available for this purpose. 1 With each evolution of treatment guidelines in this area, physicians are encouraged to intervene at increasingly early stages in disease progression with the aim of halting or attenuating pathophysiological change. Testing for the presence of target organ damage has been a standard practice in the management of patients with elevated blood pressure for some time, but new methods of detecting the earliest signs of vascular dysfunction have been attracting much attention in helping to decide which patients to treat. Physicians might, in the near future, find themselves utilizing new technologies in the assessment of their patients to stratify risk accurately and direct treatment to those with early evidence of vascular disease.
The vascular endothelium is a large autocrine, paracrine and endocrine organ comprising a single layer of cells lining every blood vessel in the body. In health, the endothelium has a wide-range of actions that contribute to vascular homoeostasis. First pioneered in 1992, measurement of brachial artery flow-mediated dilatation (FMD) has been widely utilized as a method for assessing endothelial function since shear stress normally induces nitric oxide (NO) release from endothelial cells. 2, 3 The degree of arterial dilatation detected after a period of forearm ischaemia has traditionally been viewed as a surrogate measure for NO release and hence endothelial function. Endothelial dysfunction is now viewed as one of the earliest detectable signs of impaired vascular health, and it has been suggested that its assessment might form part of cardiovascular risk quantification in the future. 4 The non-invasive nature of studying forearm blood flow has obvious advantages for the practical assessment of the endothelium, and many promising findings have been reported in this field. For instance, it has been shown that there is a strong correlation between endothelial function in forearm vessels and coronary circulations. 5, 6 FMD has potential for predicting cardiovascular events in high-risk populations [7] [8] [9] and recently it was shown for the first time that FMD can predict cardiovascular events in adults free from cardiovascular disease. 10 For FMD to be clinically useful in real-world settings, it should be easily and quickly performed and yield results that are accurate and reproducible. However, reports on the reproducibility of the technique have not always been favourable. 11 This may explain apparently contradictory reports in the literature. For example, while some authors report a reduction in FMD in diabetes [11] [12] [13] [14] with a deterioration during times of poor control, 13 others report no difference in comparison to healthy controls. 15, 16 Techniques for improving reliability of the technique have been suggested, 17 but seem overcomplicated and out of reach of practitioners outside sophisticated research laboratories.
The aim of this research was to assess reproducibility of FMD as a marker of endothelial function in subjects with Type I diabetes mellitus, by performing two diabetes-control comparator studies.
In addition, we investigated whether analysing blood flow data, which is very easily captured during the measurement of FMD but normally discarded, could be used to detect abnormalities in the subjects with diabetes.
Methods

Study details
The studies were approved by the Northern Ireland Regional Ethics Committee and conducted in line with the Declaration of Helsinki. Written consent was obtained at trial entry.
To investigate reproducibility of FMD, two studies were conducted sequentially using similar protocols. The only differences between studies were the operator (different single operator for each study) and the ultrasound machine used (different single machine for each study). A total of 71 healthy control subjects and 72 subjects with Type I diabetes mellitus were recruited. Subjects with diabetes had good diabetes control, no history of cardiovascular disease and no significant clinically detectable disease complications. Subject characteristics are detailed in Table 1 . No subjects in Study 1 were taking medication other than that listed in the table. In Study 2, six subjects were taking an angiotensin converting enzyme inhibitor, but these drugs were stopped for 2 weeks prior to trial entry.
All studies were performed in a controlled laboratory environment, and were conducted in the morning. Subjects were asked to refrain from food, drink and smoking from midnight on the day of the study. All subjects rested for 15 min in the supine position before measures were taken. Ultrasound operators were trained in an identical manner, and had 6 months' experience with the technique before the commencement of the studies. Ultrasound examinations were performed using either an ATL HDI 3500 ultrasound machine (Philips, NV, USA) (Study 1) or a MyLab 70 XVision ultrasound machine (Esaote, Genoa, Italy) (Study 2), with subjects connected to a built-in 3-lead ECG. Aqueous 'Aquasonic 100' ultrasound coupling gel (Parker, NJ, USA) was used to facilitate the ultrasound examinations.
Measurement of FMD
FMD was measured using a method that is in line with published guidelines. 3 Subjects were examined in a supine position. A sphygmomanometer cuff was placed around the upper forearm with the upper aspect placed 2.5 cm distal to the medial epicondyle. The brachial artery was identified using colour Doppler imaging and the probe was held in place using a mechanical holding system (Noga, Shlomi, Israel) attached to a Unislide manually driven X-Y table (Velmex, NY, USA). The cuff was manually rapidly inflated to a pressure 50 mmHg above the subject's systolic blood pressure, and this pressure was maintained for 270 s. The cuff was then manually rapidly deflated by opening the valve. Pulsed Doppler was used to record blood velocity data for 15 s prior to cuff release, and 30 s after cuff release. A carrying frequency of 12.5 MHz (Study 1) or 5.6 MHz (Study 2) was used with the gate size adjusted depending on the calibre of the artery. The Doppler angle was adjusted depending on the course of the artery, but was always maintained below 708.
A video signal from the ultrasound systems was transferred to the same personal computer. The picture was analysed in real-time to provide measures of vessel diameter 25 times per second, using customized software (On-line Vascular Image Analysis v.9.61, London, UK) developed on LabVIEW (National Instruments, TX, USA), which has been used in similar studies. 18 Measurement of diameter was commenced before cuff inflation, and continued until 60 s after deflation. The baseline systolic artery diameter during cuff inflation was designated b. The peak systolic artery diameter after cuff release was designated p. FMD (d) was calculated as:
Blood flow waveform analysis of post-ischaemia signals
Pulsed Doppler signals were recorded for a period of 30 s following re-establishment of forearm blood flow, and were either immediately exported for analysis (Study 1) or saved onto the ultrasound machine's internal hard drive as a series of individual screen-shots (Study 2). An example of a waveform at the time of cuff deflation is shown in Figure 1 . In Study 2, the images were exported for off-line analysis. Both maximal velocity data and a numerical representation of the ECG were extracted in both studies. An artefact rejection algorithm was employed to remove large amplitude transient noise in the signals captured. Smooth padding of zero order was applied to waveforms before they were digitally filtered using a Type 2 (stopband ripple) Chebychev IIR filter with a low-pass cutoff frequency of 30 Hz. The systolic peak and diastolic trough were identified manually on a graphical display of the waveform. The resistive index was calculated using the following formula:
where S is the peak systolic velocity and D the end diastolic velocity. Wavelet analysis of processed blood velocity waveforms was performed using a customized program written in Matlab 2007 b (The MathWorks Inc., MA, USA), utilizing the Matlab Wavelet Toolbox. The 'Daubechies 8' wavelet was used for analysis. To facilitate analysis, wavelet transform frequency data were grouped into 11 bands, and the mean absolute amplitude in each band utilized for analysis. The bands used contain frequencies in the range shown in Table 1 .
Statistical analysis
All statistical analyses were performed on SPSS for Windows v17.0 (SPSS Inc., Chicago, IL, USA). For comparisons between control subjects and disease groups, an independent group t-test was used for comparisons for all interval parameters meeting the criteria of normality and homogeneity of variance. For interval parameters not meeting these criteria, the non-parametric Mann-Whitney test was used to make comparisons between groups. Comparisons of categorical variables (e.g. current smoking-yes or no; sex-male or female) between groups were performed using the 2 -test and Fisher's exact test. Differences were considered statistically significant at P < 0.05.
Results
Subject characteristics
Subjects with diabetes were similar in both studies. Healthy control subjects were also similar in both studies. They were well-matched with regard to age, sex, weight, height, body mass index, use of aspirin and HMG-CoA reductase inhibitors, pulse rate, blood pressure, total cholesterol, HDL-and LDL cholesterol. There were more smokers in Study 2 (20.5% vs. 0%, P = 0.007), and triglyceride levels were higher in Study 1 (1.25 mmol/l, 0.86-1.99 vs. 0.86, 0.66-1.26, P = 0.041).
There were inevitable small differences between healthy control subjects and subjects with diabetes in both studies as detailed in Table 2 .
FMD
Brachial artery diameters were similar between subjects with diabetes and control subjects in both studies. In Study 1, FMD was significantly impaired in subjects with Type I diabetes when compared with controls (median 4.35%, interquartile range 3.10-4.80 vs. 6.50, 4.79-9.42, P < 0.001). In Study 2, however, no difference was detected between groups, as detailed in Table 3 .
Wavelet transform analysis of post-ischaemia forearm blood flow waveforms
When the first ten pulse waveforms following cuff deflation were averaged and analysed using the wavelet transform, abnormalities were detected in signals recorded from subjects with diabetes in both studies as detailed in Table 4 . In study 1, the amplitude was lower for subjects with diabetes than controls in bands 8 (mean 5.13 cms À1 , standard error 0.43 vs. 6.90, 0.76, P = 0.035) and 11 (34.30, 2.12 vs. 42.55, 3.00, P = 0.025). In study 2, the amplitude was lower for subjects with diabetes than controls in bands 6 (mean 16.54 cms À1 , standard error 0.80 vs. 19.15, 0.93, P = 0.037) and 11 (92.72, 3.70 vs. 110.75, 4.72, P = 0.004). There was a trend towards lower amplitude for subjects with diabetes in band 9 (P = 0.090).
Discussion
Endothelial dysfunction is becoming increasingly recognized as the initiating event in atherosclerosis, 19 and is also involved in plaque progression and the occurrence of atherosclerotic complications. 20 Many cardiovascular risk factors are associated with increased oxidative stress. 21 By increasing reactive oxygen species such risk factors effectively lower bioavailability of NO, thus promoting cell damage. This could represent a single unifying pathogenic hypothesis for atherosclerosis. Similarly, a growing body of reports links the earliest clinically detectable evidence of microvascular damage with an increased long-term cardiovascular risk for the individual concerned. [22] [23] [24] [25] [26] There is, therefore, the need to develop a means for accurately and reproducibly detecting and quantifying microvascular damage at an early stage. Furthermore, to be useful in the clinical arena, the technique should be easily mastered, quickly performed, welltolerated by the subject and ideally be performed on equipment already in place. On the surface, the measurement of brachial artery FMD certainly appears as a reasonable candidate technique to meet these requirements.
However, the data presented in this article highlight serious concerns over the reproducibility of results when FMD is measured as an indicator of endothelial function. When FMD was compared between two groups of well-matched healthy control subjects and subjects with diabetes using identically trained operators and similar protocols, contradictory results were found. In the first study, FMD was found to be significantly reduced in those with diabetes and in the second, no difference with healthy controls was detected. Such a discrepancy in results is apparent after reviewing relevant literature. While some authors report a reduction in FMD in diabetes, [11] [12] [13] [14] others report no difference in comparison to healthy controls. 15, 16 With the effects of publication bias favouring the publishing of positive studies, the overall effect may be even more neutral.
Another problem with measuring FMD is in the interpretation of what impaired FMD actually represents. At its simplest level, the degree of FMD in an individual can be taken as a metric for endothelial NO production, and this is how FMD is presented in the majority of papers. However, many more factors govern the degree of dilatation observed in any individual for any given flow stimulus. For instance, it has been shown that FMD is strongly dependent on arterial size. It can be predicted that shear stress will be increased in small arteries from Poiseuille's equation. 27 It would therefore be expected that shear stress would be higher in a smaller vessel, thus producing a higher FMD. Indeed, in the Cardiovascular Health Study, it was found that the brachial artery diameter itself predicted cardiovascular events. 9 It has also been suggested that sensing of shear stress might be impaired in diabetes. 19 Furthermore, once released, NO may have a limited lifespan in subjects with diabetes. This can relate to scavenging by reactive oxygen species or to quenching of NO by advanced glycation end products. 28 Hyperglycaemia can interfere with the production of NO-induced guanylate cyclase activation. 29 In addition, vascular smooth muscle cells may not relax normally in diabetes. 2, 12 Local distensibility of the brachial artery must also play a factor, since a rigid artery would not be expected to dilate significantly regardless of the factors mentioned above. A difference in any of these factors could account for a difference in FMD between individuals.
A third issue is that measurement of FMD, while theoretically simplistic, is actually very technically demanding and it has been shown that the within person reproducibility of measures is far from consistent. 11 Additionally, the interpretation of diameter measurements before and after ischaemia is open to bias, since there is often a great degree of noise and movement artefact in the diameter signal recorded.
For several reasons therefore-questionable reproducibility, uncertainty as to what FMD represents, technical difficulty of the technique and difficulty in interpreting results-it is hard to envisage how the technique could ever be utilized outside a research laboratory. Interestingly, a recently published longitudinal study reported that the measurement of FMD in a healthy population failed to assist in the prediction of future cardiovascular events over a mean of over 7 years. 30 However, all may not be lost for the use of ultrasound in assessing the brachial artery after a period of forearm ischaemia. Evidence is presented in this article that suggests that blood flow data that are normally discarded during the measurement of FMD may be useful and reproducible in discriminating between health and disease states. The phenomena of pulse wave propagation and wave reflection have been widely studied in large blood vessels, as aortic pulse-wave velocity and augmentation index, respectively. 31, 32 Wave reflection occurs as a result of changes in diameter and stiffness of vessels, and must therefore occur in smaller arteries and microvessels also. The challenge facing researchers is how best to detect and characterize these reflected signals. The blood velocity profile obtained after cuff deflation during an FMD experiment offers an excellent opportunity for studying blood flow in a conduit artery supplying a distal micro-circulatory bed, since the forearm is converted into an extremely low resistance vascular circuit because of ischaemia.
The wavelet transform is a mathematical tool that was introduced in the mid-1980 s to assist in the analysis of seismic signals. 33 Its use permits the decomposition of a signal into its constituent frequency components and their corresponding position in time. Wavelet transform analysis has many theoretical advantages over the more widely used Fourier techniques when applied to biological signals, [34] [35] [36] and has been widely adopted in disciplines outside medicine. [37] [38] [39] Most reports of the use of the wavelet transform in analysing blood flow data have been in the field of laser Doppler flowmetry, where wavelet-based analysis has been described as the method of choice. 40 The current study adds to this body of evidence suggesting that the wavelet transform is a useful tool for characterizing human blood velocity waveforms. We have shown that the technique can discriminate disease from a healthy state even when the disease in question is very well-controlled when traditional parameters are considered alone. In addition, similar results were obtained in two case-control studies suggesting that results are reproducible-unlike those seen when FMD was considered. Whether or not this technique has a role in the future assessment of cardiovascular risk in a clinic setting will depend on further studies being carried out in this area.
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